Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
SynKinase
MBP146-78
CHF 0.00
In stock
SYN-1227-M0011 mgCHF 99.00
SYN-1227-M0055 mgCHF 156.00
SYN-1227-M01010 mgCHF 213.00
SYN-1227-M05050 mgCHF 780.00
SYN-1227-M100100 mgINQ
Product Details | |
---|---|
Synonyms | 4-[2-(4-Fluorophenyl)-5-(1-methylpiperidine-4-yl)-1H-pyrrol-3-yl] pyridine |
Product Type | Chemical |
Properties | |
Formula | C21H22FN3 |
MW | 335.4 |
CAS | 188343-77-3 |
Purity Chemicals | ≥95% (HPLC) |
Appearance | Solid. |
Solubility | Soluble in DMSO. |
Declaration | Manufactured by SynKinase. |
Other Product Data | Target: PKG | Kinase Group: AGC | Substrate: Serine-Threonine |
InChi Key | RBWNFHXBUDPAIO-UHFFFAOYSA-N |
Shipping and Handling | |
Shipping | AMBIENT |
Short Term Storage | +4°C |
Long Term Storage | -20°C |
Use/Stability | Stable for at least 2 years after receipt when stored at -20°C. |
Documents | |
MSDS | Inquire |
Product Specification Sheet | |
Datasheet | Download PDF |
Description
MBP146-78 inhibits the growth of Eimeria spp. both in vitro and in vivo. The molecular target of MBP146-78 was identified as cGMP-dependent protein kinase (PKG) using a tritiated analogue to purify a approximately 120-kDa protein from lysates of Eimeria tenella. This represents the first example of a protozoal PKG. MBP146-78 is a potent inhibitor of both soluble and membrane-associated isoforms of native PKG, as well as recombinant enzyme, with an IC50 of <1nm.
Product References
- Purification and molecular characterization of cGMP-dependent protein kinase from Apicomplexan parasites. A novel chemotherapeutic target: A.M. Gurnett, et al.; J. Biol. Chem. 277, 15913 (2002)
- Toxoplasma gondii cyclic GMP-dependent kinase: chemotherapeutic targeting of an essential parasite protein kinase: R.G. Donald, et al.; Eukaryot. Cell 1, 317 (2002)
- A role for coccidian cGMP-dependent protein kinase in motility and invasion: H.I. Wiersma, et al.; Int. J. Parasitol. 34, 369 (2004)
- Characterization of Plasmodium falciparum cGMP-dependent protein kinase (PfPKG): antiparasitic activity of a PKG inhibitor: C.A. Diaz, et al.; Mol. Biochem. Parasitol. 146, 78 (2006)
- Anticoccidial kinase inhibitors: identification of protein kinase targets secondary to cGMP-dependent protein kinase: R.G. Donald, et al.; Mol. Biochem. Parasitol. 149, 86 (2006)